Pharsight

Drugs that contain Risedronate Sodium

1. Actonel patents expiration

ACTONEL's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7192938 APIL Method of treatment using bisphosphonic acid
May, 2023

(9 months ago)

US7718634 APIL Method of treatment using bisphosphonic acid
May, 2023

(9 months ago)

US7718634

(Pediatric)

APIL Method of treatment using bisphosphonic acid
Nov, 2023

(3 months ago)

US7192938

(Pediatric)

APIL Method of treatment using bisphosphonic acid
Nov, 2023

(3 months ago)

Market Authorisation Date: 27 March, 1998

Treatment: Prevention and treatment of osteoporosis; Treatment of osteoporosis in postmenopausal women

Dosage: TABLET;ORAL

How can I launch a generic of ACTONEL before it's drug patent expiration?
More Information on Dosage

ACTONEL family patents

Family Patents

2. Atelvia patents expiration

ATELVIA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8246989 APIL Dosage forms of bisphosphonates
Jan, 2026

(1 year, 10 months from now)

US7645459 APIL Dosage forms of bisphosphonates
Jan, 2028

(3 years from now)

US7645460 APIL Dosage forms of risedronate
Jan, 2028

(3 years from now)

Market Authorisation Date: 08 October, 2010

Treatment: Treatment of osteoporosis in postmenopausal women

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of ATELVIA before it's drug patent expiration?
More Information on Dosage

ATELVIA family patents

Family Patents